Metraipolis › archive › dc_5971ef2cd2b0
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer… — Europe PMC PMID:41896216
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41896216
- DOI
- 10.1038/s41419-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T19:27:53.558Z
- SHA-256 of the archived text
427673f59d39fdf29cf2f3bd47a6fc04ab0e53d8d39cd617bfec1d90ba966bcb- Stable URL of this page
https://metraipolis.com/documento/dc_5971ef2cd2b0
How to cite
UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer… — Europe PMC PMID:41896216 — Europe PMC (en), https://europepmc.org/article/MED/41896216 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5971ef2cd2b0 (Metraipolis archive dc_5971ef2cd2b0, sha256 427673f59d39fdf29cf2f3bd47a6fc04ab0e53d8d39cd617bfec1d90ba966bcb)
BibTeX
@misc{dc5971ef2cd2b0,
title = {UPR/ATF4/Noxa pathway overactivation through SERCA2 inhibition or ONC201 treatment combined with ABT-737 triggers apoptosis in chemoresistant ovarian cancer… — Europe PMC PMID:41896216},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41896216},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5971ef2cd2b0; sha256 427673f59d39fdf29cf2f3bd47a6fc04ab0e53d8d39cd617bfec1d90ba966bcb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41896216. Agents can read the archived copy with the MCP tool read_document.